Effects of switching from olanzapine, quetiapine, and risperidone to aripiprazole on 10-year coronary heart disease risk and metabolic syndrome status: Results from a randomized controlled trial
2013 ◽
Vol 146
(1-3)
◽
pp. 190-195
◽
2012 ◽
Vol 39
(11)
◽
pp. 1065-1074
◽
2020 ◽
Vol 45
(7)
◽
pp. 801-804
2018 ◽
Vol 71
(16)
◽
pp. S38
2016 ◽
Vol 39
(11)
◽
pp. 1337-1346
◽
2009 ◽
Vol 203
(1)
◽
pp. 243-248
◽
2006 ◽
Vol 166
(11)
◽
pp. 1218
◽